{"id":852,"date":"2026-04-24T21:32:15","date_gmt":"2026-04-24T19:32:15","guid":{"rendered":"https:\/\/studienportal-endometriumkrebs.de\/noggo-s35-expression-xxi-21\/"},"modified":"2026-07-22T12:01:36","modified_gmt":"2026-07-22T10:01:36","slug":"noggo-s35-expression-xxi-21","status":"publish","type":"post","link":"https:\/\/studienportal-endometriumkrebs.de\/tr\/noggo-s35-expression-xxi-21\/","title":{"rendered":"NOGGO S35 \u2013 Expression XXI \u2013 (21)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"852\" class=\"elementor elementor-852 elementor-498\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2c69b70e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"2c69b70e\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4986c601\" data-id=\"4986c601\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6588708f elementor-widget elementor-widget-heading\" data-id=\"6588708f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">NOGGO S35 \/ <b>Expression XXI \u2013 (21) \/ SARA \u00c7al\u0131\u015fmas\u0131<\/b><\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-35c6b8be elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"35c6b8be\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-590f42d8\" data-id=\"590f42d8\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1514f64a headline elementor-widget elementor-widget-heading\" data-id=\"1514f64a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Rahim Kanseri Olan Hastalar\u0131n Ya\u015fam Kalitesi Anketi \u00c7al\u0131\u015fmas\u0131<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2d47951f elementor-widget elementor-widget-text-editor\" data-id=\"2d47951f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>SARA \u00c7al\u0131\u015fmas\u0131, rahim kanseri olan hastalar\u0131n ya\u015fam kalitesine y\u00f6nelik Avrupa \u00e7ap\u0131nda bir anket \u00e7al\u0131\u015fmas\u0131d\u0131r. Ama\u00e7, tedavinin akut ve uzun vadeli yan etkilerini ve bunlar\u0131n hastalar\u0131n g\u00fcnl\u00fck ya\u015famlar\u0131 ile refahlar\u0131 \u00fczerindeki etkilerini kaydetmektir. <\/p><h2><strong>Ankette neler inceleniyor?<\/strong><\/h2><p>Rahim kanseri, geli\u015fmi\u015f \u00fclkelerde kad\u0131nlarda en s\u0131k g\u00f6r\u00fclen kanser t\u00fcrlerinden biridir \u2013 meme, ba\u011f\u0131rsak ve akci\u011fer kanserinden sonra d\u00f6rd\u00fcnc\u00fc s\u0131rada yer al\u0131r. \u00c7o\u011fu durumda hastal\u0131k erken te\u015fhis edilir, bu da iyile\u015fme \u015fans\u0131n\u0131 art\u0131r\u0131r. \u0130yi sa\u011fkal\u0131m oranlar\u0131na ra\u011fmen, tedavi uzun vadede ya\u015fam kalitesini etkileyebilecek yan etkilere neden olabilir. Bunlar fiziksel (\u00f6rn. polin\u00f6ropati veya sa\u00e7 d\u00f6k\u00fclmesi gibi sinir hasarlar\u0131), psikolojik veya sosyal olabilir. SARA \u00c7al\u0131\u015fmas\u0131, bu zorluklar\u0131n nas\u0131l deneyimlendi\u011fini ve hastalar i\u00e7in uzun vadeli sonu\u00e7lar\u0131n\u0131 daha iyi anlamay\u0131 ama\u00e7lamaktad\u0131r. Anket, rahim kanseriyle ya\u015fam\u0131n bir\u00e7ok y\u00f6n\u00fcn\u00fc dikkate almaktad\u0131r: e\u015flik eden hastal\u0131klar, genel sa\u011fl\u0131k durumu, birden fazla ila\u00e7 kullan\u0131m\u0131 (polifarmasi), yan etkiler, psikolojik durum, g\u00fcnl\u00fck ya\u015fam, ili\u015fkiler, \u00e7al\u0131\u015fma durumu ve tedavi se\u00e7enekleri hakk\u0131nda bilgi d\u00fczeyi.     <\/p><h2 class=\"peach\"><strong>Anketin amac\u0131 nedir?<\/strong><\/h2><p>\u00c7al\u0131\u015fman\u0131n temel amac\u0131, belirli yan etkilerin \u2013 \u00f6zellikle sinir hasar\u0131 (polin\u00f6ropati) ve sa\u00e7 d\u00f6k\u00fclmesi \u2013 s\u0131kl\u0131\u011f\u0131n\u0131 kaydetmek ve bunlar\u0131n ya\u015fam kalitesini ne kadar etkiledi\u011fini de\u011ferlendirmektir.<br\/>Ayr\u0131ca a\u015fa\u011f\u0131daki noktalar da incelenecektir:<\/p><ul><li>Tedavi tercihleri ve tedaviye uyum (tedavilere uyulup uyulmad\u0131\u011f\u0131 ve ne kadar iyi uyuldu\u011fu)<\/li><li>Hastal\u0131\u011f\u0131n neden oldu\u011fu finansal ve zamansal y\u00fckler<\/li><li>Hastalar\u0131n tedavi se\u00e7enekleri ve t\u0131bbi k\u0131lavuzlar hakk\u0131nda ne kadar iyi bilgilendirildiklerini hissettikleri<\/li><\/ul><h2><strong>Anket s\u00fcreci nas\u0131l i\u015fliyor?<\/strong><\/h2><p>Toplamda yakla\u015f\u0131k 500 hasta \u00e7al\u0131\u015fmaya dahil edilecek, bunlardan 100&#8217;\u00fc Almanya&#8217;dan olacak. SARA \u00c7al\u0131\u015fmas\u0131na kat\u0131l\u0131m, hastal\u0131\u011f\u0131n hangi evresinde olduklar\u0131na veya hangi tedaviyi ald\u0131klar\u0131na (veya alm\u0131\u015f olduklar\u0131na) bak\u0131lmaks\u0131z\u0131n, etkilenen kad\u0131nlar\u0131n doldurabilece\u011fi bir anket arac\u0131l\u0131\u011f\u0131yla ger\u00e7ekle\u015fir. \u00dc\u00e7 hasta grubu kar\u015f\u0131la\u015ft\u0131r\u0131lacakt\u0131r:  <\/p><ul><li><strong>A Grubu:<\/strong> \u0130lk kez rahim kanseri te\u015fhisi konmu\u015f kad\u0131nlar<\/li><li><strong>B Grubu:<\/strong> Hastal\u0131\u011f\u0131 n\u00fckseden (tekrarlayan) kad\u0131nlar<\/li><li><strong>C Grubu:<\/strong> Tedaviden sonraki d\u00f6nemde olan kad\u0131nlar<\/li><\/ul><h2 class=\"peach\"><strong>Riskler var m\u0131?<\/strong><\/h2><p>Expression 21 bir anket \u00e7al\u0131\u015fmas\u0131 oldu\u011fundan, kat\u0131l\u0131m riski bulunmamaktad\u0131r.<\/p><h2><strong>Kat\u0131l\u0131m ko\u015fullar\u0131:<\/strong><\/h2><p>Anket g\u00f6n\u00fcll\u00fcl\u00fck esas\u0131na dayan\u0131r ve hastal\u0131\u011f\u0131n ilk kez ortaya \u00e7\u0131k\u0131p \u00e7\u0131kmad\u0131\u011f\u0131na veya tekrarlay\u0131p tekrarlamad\u0131\u011f\u0131na bak\u0131lmaks\u0131z\u0131n rahim kanserinden etkilenen t\u00fcm kad\u0131nlara y\u00f6neliktir. Kat\u0131l\u0131m i\u00e7in minimum ya\u015f 18&#8217;dir. <\/p><h2 class=\"peach\"><strong>Ankete nerede kat\u0131labilirim?<\/strong><\/h2><p>\u015eu anda hastalar, kat\u0131l\u0131mc\u0131 merkezler arac\u0131l\u0131\u011f\u0131yla \u00e7al\u0131\u015fmaya kat\u0131labilirler. Yak\u0131nda \u00e7evrimi\u00e7i kat\u0131l\u0131m da m\u00fcmk\u00fcn olacakt\u0131r. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-979c0d3 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"979c0d3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ce28a8f elementor-widget elementor-widget-button\" data-id=\"ce28a8f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/studienportal-endometriumkrebs.de\/deutschlandkarte\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-arrow-right\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M190.5 66.9l22.2-22.2c9.4-9.4 24.6-9.4 33.9 0L441 239c9.4 9.4 9.4 24.6 0 33.9L246.6 467.3c-9.4 9.4-24.6 9.4-33.9 0l-22.2-22.2c-9.5-9.5-9.3-25 .4-34.3L311.4 296H24c-13.3 0-24-10.7-24-24v-32c0-13.3 10.7-24 24-24h287.4L190.9 101.2c-9.8-9.3-10-24.8-.4-34.3z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Almanya haritas\u0131na<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t<div class=\"elementor-element elementor-element-90fff85 e-flex e-con-boxed e-con e-parent\" data-id=\"90fff85\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8fae81f elementor-widget elementor-widget-button\" data-id=\"8fae81f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/iuvando.de\/kontakt\/\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-arrow-right\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M190.5 66.9l22.2-22.2c9.4-9.4 24.6-9.4 33.9 0L441 239c9.4 9.4 9.4 24.6 0 33.9L246.6 467.3c-9.4 9.4-24.6 9.4-33.9 0l-22.2-22.2c-9.5-9.5-9.3-25 .4-34.3L311.4 296H24c-13.3 0-24-10.7-24-24v-32c0-13.3 10.7-24 24-24h287.4L190.9 101.2c-9.8-9.3-10-24.8-.4-34.3z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Kat\u0131l\u0131m uygunlu\u011funu kontrol ettir<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>NOGGO S35 \/ Expression XXI \u2013 (21) \/ SARA \u00c7al\u0131\u015fmas\u0131 Rahim Kanseri Olan Hastalar\u0131n Ya\u015fam Kalitesi Anketi \u00c7al\u0131\u015fmas\u0131 SARA \u00c7al\u0131\u015fmas\u0131, rahim kanseri olan hastalar\u0131n ya\u015fam kalitesine y\u00f6nelik Avrupa \u00e7ap\u0131nda bir anket \u00e7al\u0131\u015fmas\u0131d\u0131r. Ama\u00e7, tedavinin akut ve uzun vadeli yan etkilerini ve bunlar\u0131n hastalar\u0131n g\u00fcnl\u00fck ya\u015famlar\u0131 ile refahlar\u0131 \u00fczerindeki etkilerini kaydetmektir. Ankette neler inceleniyor? Rahim kanseri, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[37],"tags":[],"class_list":["post-852","post","type-post","status-publish","format-standard","hentry","category-calismalar"],"acf":[],"_links":{"self":[{"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/posts\/852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/comments?post=852"}],"version-history":[{"count":1,"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/posts\/852\/revisions"}],"predecessor-version":[{"id":857,"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/posts\/852\/revisions\/857"}],"wp:attachment":[{"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/media?parent=852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/categories?post=852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/tr\/wp-json\/wp\/v2\/tags?post=852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}